drugset / Trial / NCT06178523

Cost-effective Treatment of Unexplained Infertility

NCT06178523

Phase 4 Completed 900 enrolled Batterjee Medical College
RandomizedParallel-groupDouble-blindTreatment

Summary

The issue of unexplained infertility that Southam brought up in 1960 is still a problem today. Despite improvements in infertility assessment, many couples still don't know why they are infertile. Even with the use of the most advanced ovulation detectors, fallopian tube patency tests, and semen evaluations, competency cannot identify every potential flaw in the intricate processes leading to conception. Unexplained infertility will be a challenge for both biological and clinical researchers since it results from these gaps in our understanding of fertilization and from our incapacity to use all of the current evidence-based information.

Timeline

Start
2024-01-01
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sildenafil Unknown 25 mg Intravenous
Comparator Clomiphene Other / unclassified 100 mg

Indications